Trimegestone (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Trimegestone" in Vietnamese language version.

refsWebsite

Global rank Vietnamese rank

11books.google.com

3^rd place

6^th place

9doi.org

2^nd place

8nih.gov

4^th place

7^th place

6springer.com

274^th place

484^th place

1hormonebalance.org

low place

1drugs.com

399^th place

214^th place

1micromedexsolutions.com

low place

1kup.at

low place

1medicinescomplete.com

low place

1worldcat.org

5^th place

13^th place

books.google.com

Howard J.A. Carp, MB, BS, FRCOG (9 tháng 4 năm 2015). Progestogens in Obstetrics and Gynecology. Springer. tr. 38–. ISBN 978-3-319-14385-9.Quản lý CS1: nhiều tên: danh sách tác giả (liên kết)
M. Beato (1 tháng 1 năm 1980). Steroid Induced Uterine Proteins: Proceedings of the International Symposium on Steroid Induced Uterine Proteins Held in Marburg, West Germany, 28-29 September, 1979. Elsevier/North-Holland Biomedical Press. tr. 227–228, 227–233.
Annual Reports in Medicinal Chemistry. Academic Press. 31 tháng 12 năm 2012. tr. 273, 647. ISBN 978-0-12-397214-9.
John Bodenhan Taylor; D. J. Triggle (2007). Comprehensive Medicinal Chemistry II: Global perspective. Elsevier. ISBN 978-0-08-044514-4.
Paula Briggs; Gabor Kovacs (11 tháng 7 năm 2013). Contraception: A Casebook from Menarche to Menopause. Cambridge University Press. tr. 52–. ISBN 978-1-107-43611-4.
Thomas L. Lemke; David A. Williams (24 tháng 1 năm 2012). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. tr. 1403–. ISBN 978-1-60913-345-0.
Eckhard Ottow; Hilmar Weinmann (8 tháng 9 năm 2008). Nuclear Receptors as Drug Targets. John Wiley & Sons. tr. 208–. ISBN 978-3-527-62330-3.
Martin Birkhauser; David Barlow; Morris Notelovitz; Margaret Rees (12 tháng 8 năm 2005). Health Plan for the Adult Woman: Management Handbook. CRC Press. tr. 24–. ISBN 978-0-203-49009-9.
C.R. Ganellin; David J. Triggle (21 tháng 11 năm 1996). Dictionary of Pharmacological Agents. CRC Press. tr. 2063–. ISBN 978-0-412-46630-4.
Gerald Litwack (2 tháng 12 năm 2012). Biochemical Actions of Hormones. Elsevier. tr. 314–. ISBN 978-0-323-15344-7.
Annette M. Doherty (2002). Annual Reports in Medicinal Chemistry. Elsevier. tr. 273–. ISBN 978-0-12-040537-4.

doi.org

Kuhl H (2005). “Pharmacology of estrogens and progestogens: influence of different routes of administration” (PDF). Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947.
Stanczyk FZ (2002). “Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception” (PDF). Rev Endocr Metab Disord. 3 (3): 211–24. doi:10.1023/A:1020072325818. PMID 12215716.
Sitruk-Ware R, Bossemeyer R, Bouchard P (tháng 6 năm 2007). “Preclinical and clinical properties of trimegestone: a potent and selective progestin”. Gynecol. Endocrinol. 23 (6): 310–9. doi:10.1080/09513590701267727. PMID 17616854.
Wahab M, Al-Azzawi F (tháng 9 năm 2001). “Trimegestone: expanding therapeutic choices for the treatment of the menopause”. Expert Opin Investig Drugs. 10 (9): 1737–44. doi:10.1517/13543784.10.9.1737. PMID 11772282.
Sitruk-Ware R (2004). “New progestogens: a review of their effects in perimenopausal and postmenopausal women”. Drugs Aging. 21 (13): 865–83. doi:10.2165/00002512-200421130-00004. PMID 15493951.
Winneker RC, Bitran D, Zhang Z (2003). “The preclinical biology of a new potent and selective progestin: trimegestone”. Steroids. 68 (10–13): 915–20. doi:10.1016/s0039-128x(03)00142-9. PMID 14667983.
Philibert D, Bouchoux F, Degryse M, Lecaque D, Petit F, Gaillard M (tháng 10 năm 1999). “The pharmacological profile of a novel norpregnance progestin (trimegestone)”. Gynecol. Endocrinol. 13 (5): 316–26. doi:10.3109/09513599909167574. PMID 10599548.
Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH (2008). “Classification and pharmacology of progestins”. Maturitas. 61 (1–2): 171–80. doi:10.1016/j.maturitas.2008.11.013. PMID 19434889.
Bernardelli, Patrick; Gaudillière, Bernard; Vergne, Fabrice (2002). Chapter 26. To market, to market - 2001. Annual Reports in Medicinal Chemistry. 37. tr. 257–277. doi:10.1016/S0065-7743(02)37027-1. ISBN 9780120405374. ISSN 0065-7743.

drugs.com

“Trimegestone”.

hormonebalance.org

Kuhl H (2005). “Pharmacology of estrogens and progestogens: influence of different routes of administration” (PDF). Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947.

kup.at

Kuhl H (2011). “Pharmacology of progestogens” (PDF). Journal für Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology. 8 (Special Issue 1): 157–176.

medicinescomplete.com

Sweetman, Sean C. biên tập (2009). “Sex hormones and their modulators”. Martindale: The Complete Drug Reference (ấn bản thứ 36). London: Pharmaceutical Press. tr. 2082. ISBN 978-0-85369-840-1.

micromedexsolutions.com

“Micromedex Products: Please Login”.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kuhl H (2005). “Pharmacology of estrogens and progestogens: influence of different routes of administration” (PDF). Climacteric. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947.
Stanczyk FZ (2002). “Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception” (PDF). Rev Endocr Metab Disord. 3 (3): 211–24. doi:10.1023/A:1020072325818. PMID 12215716.
Sitruk-Ware R, Bossemeyer R, Bouchard P (tháng 6 năm 2007). “Preclinical and clinical properties of trimegestone: a potent and selective progestin”. Gynecol. Endocrinol. 23 (6): 310–9. doi:10.1080/09513590701267727. PMID 17616854.
Wahab M, Al-Azzawi F (tháng 9 năm 2001). “Trimegestone: expanding therapeutic choices for the treatment of the menopause”. Expert Opin Investig Drugs. 10 (9): 1737–44. doi:10.1517/13543784.10.9.1737. PMID 11772282.
Sitruk-Ware R (2004). “New progestogens: a review of their effects in perimenopausal and postmenopausal women”. Drugs Aging. 21 (13): 865–83. doi:10.2165/00002512-200421130-00004. PMID 15493951.
Winneker RC, Bitran D, Zhang Z (2003). “The preclinical biology of a new potent and selective progestin: trimegestone”. Steroids. 68 (10–13): 915–20. doi:10.1016/s0039-128x(03)00142-9. PMID 14667983.
Philibert D, Bouchoux F, Degryse M, Lecaque D, Petit F, Gaillard M (tháng 10 năm 1999). “The pharmacological profile of a novel norpregnance progestin (trimegestone)”. Gynecol. Endocrinol. 13 (5): 316–26. doi:10.3109/09513599909167574. PMID 10599548.
Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, Thijssen JH (2008). “Classification and pharmacology of progestins”. Maturitas. 61 (1–2): 171–80. doi:10.1016/j.maturitas.2008.11.013. PMID 19434889.

springer.com

adisinsight.springer.com

link.springer.com

Stanczyk FZ (2002). “Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception” (PDF). Rev Endocr Metab Disord. 3 (3): 211–24. doi:10.1023/A:1020072325818. PMID 12215716.

worldcat.org

Bernardelli, Patrick; Gaudillière, Bernard; Vergne, Fabrice (2002). Chapter 26. To market, to market - 2001. Annual Reports in Medicinal Chemistry. 37. tr. 257–277. doi:10.1016/S0065-7743(02)37027-1. ISBN 9780120405374. ISSN 0065-7743.